September 17, 2014 7:21 PM ET

Company Overview of The Global Alliance for TB Drug Development

Company Overview

The Global Alliance for TB Drug Development is a non-profit organization.

,  

United States

Founded in 2000

Key Executives for The Global Alliance for TB Drug Development

Chief Executive Officer
Age: 65
President of Stakeholders Association and Director
Head of Research
Head of Project Management
Director of Policy
Compensation as of Fiscal Year 2014.

The Global Alliance for TB Drug Development Key Developments

The Global Alliance for TB Drug Development Appoints Willo Brock as Senior Vice President, External Affairs

The Global Alliance for TB Drug Development (TB Alliance) announced the appointment of Willo Brock as Senior Vice President, External Affairs. Mr. Brock comes to TB Alliance having most recently served as Head of Major Donor Relations for WWF International (formerly known as the World Wildlife Fund). In his role, Mr. Brock will guide the TB Alliance's resource development, advocacy and policy, and community and stakeholder engagement strategies, which are focused on building global support for the development of promising new treatments to fight tuberculosis (TB). Mr. Brock comes to the TB Alliance with nearly 20 years of experience in international development, and has worked in more than 60 countries around the world. At WWF International, he led major donor relations for the $100 million Campaign for a Living Planet.

Sanofi and The Global Alliance for TB Drug Development Announce Collaboration to Accelerate New Treatments Against Tuberculosis

Sanofi and The Global Alliance for TB Drug Development announced a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB). Under the agreement, Sanofi and TB Alliance will collaborate to further optimize and develop several novel compounds in Sanofi's library that have demonstrated activity against Mycobacterium tuberculosis, the bacterium that causes tuberculosis. This includes in-depth research of lead compounds based upon identified chemical derivatives of natural products, which have promising potential to treat all forms of tuberculosis, and the chemical optimization of other series of compounds that have been identified as hits through high-throughput screening.

Similar Private Companies By Industry

Company Name Region
Mike Hall Chevrolet, Inc. United States
Massachusetts Higher Education Assistance Corporation United States
RIC International Inc. United States
Bethell Living Trust United States
Summit Capital USA, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact The Global Alliance for TB Drug Development, please visit www.tballiance.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.